Evidence map›Paper›PMID 41141903›Full record

ArticleFrontiers in artificial intelligence2025

There are significant differences among artificial intelligence large language models when answering scientific questions.

Francisco Javier Álvarez-Martínez, Luis Esteban, Lucas Frungillo, Estefanía Butassi, Alessandro Zambon, María Herranz-López, Mario Aranda, Federica Pollastro, Anne Sylvie Tixier, Jose V Garcia-Perez and 8 more

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Francisco Javier Álvarez-MartínezInstitute of Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universitas Miguel Hernández (UMH), Elche, Spain.
Luis EstebanCEDER-CIEMAT, Centro de Desarrollo de Energías Renovables-Centro de Investigaciones Energéticas Medioambientales y Tecnológicas, Lubia, Spain.
Lucas FrungilloSchool of Biological Sciences, Institute of Molecular Plant Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Estefanía ButassiÁrea Farmacognosia, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina.
Alessandro ZambonDepartment of Civil, Chemical, Environmental, and Materials Engineering, University of Bologna, Bologna, Italy.
María Herranz-LópezInstitute of Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universitas Miguel Hernández (UMH), Elche, Spain.
Mario ArandaDepartamento de Química y Farmacia, Pontificia Universidad Católica de Chile, Macul, Santiago, Chile.
Federica PollastroDepartment of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy.
Anne Sylvie TixierAvignon Université, INRAE, UMR SQPOV, Avignon, France.
Jose V Garcia-PerezInstituto de Ingeniería de Alimentos-FoodUPV, Universitat Politécnica de València, Valencia, Spain.
David Arráez-RománDepartment of Analytical Chemistry, University of Granada, Granada, Spain.
Andrew RossSchool of Chemical and Process Engineering, University of Leeds, Leeds, United Kingdom.
Pedro MenaHuman Nutrition Unit, Department of Food and Drug, University of Parma, Parma, Italy.
Ru Angelie Edrada-EbelStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
James LyngUCD School of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
Vicente MicolInstitute of Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universitas Miguel Hernández (UMH), Elche, Spain.
Fernando Borrás-RocherDepartamento de Estadística, Matemáticas e Informática, Universidad Miguel Hernández, Elche, Alicante, Spain.
Enrique Barrajón-CatalánInstitute of Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universitas Miguel Hernández (UMH), Elche, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study investigates the efficacy of large language models (LLMs) for generating accurate scientific responses through a comparative evaluation of five prominent free models: Claude 3.5 Sonnet, Gemini, ChatGPT 4o, Mistral Large 2, and Llama 3.1 70B. Methods: Sixteen expert scientific reviewers assessed these models in terms of depth, accuracy, relevance, and clarity. Results: Claude 3.5 Sonnet emerged as the highest scoring model, followed by Gemini, with notable variability among the other models. Additionally, retrieval-augmented generation (RAG) techniques were applied to improve LLM performance, and prompts were refined to improve answers. The results indicate that although LLMs such as Claude 3.5 Sonnet have potential for scientific tasks, other models may require more development or additional prompt engineering to reach comparable accuracy. Reviewers' perceptions of artificial intelligence (AI) utility and trustworthiness showed a positive shift after evaluation. However, ethical concerns, particularly with respect to transparency and disclosure, remained consistent. Discussion: The study highlights the need for structured frameworks for evaluating LLMs and ethical considerations essential for responsible AI integration in scientific research. These findings should be interpreted with caution, as the limited sample size and domain-specific focus of the exam questions restrict the generalizability of the results.

Indexed as

artificial intelligencelarge language modelsprompt engineeringretrieval-augmented generationscientific evaluation

Identifiers

PMID41141903
PMCPMC12547693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.